Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Small Cell × GSK2879552 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Small Cell Lung Carcinoma 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Carcinoma, Small Cell 1

Interventions

belinostat 2 pembrolizumab 1 alvocidib 1 Topotecan 1 Taxes 1 Sorafenib 1 Paclitaxel 1 Nortriptyline 1 GSK2879552 1 Fluorouracil 1 Depsipeptides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02034123 2019-12-06

Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma

GlaxoSmithKline

Phase 1 Terminated

29 enrolled 34 charts

Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡